BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Marc Kahn who wrote (232)	7/14/1998 9:22:00 AM
From: James Strauss	Read Replies (1) of 534

Marc: Excellent post!!! It does look like Bioject Mgmt is on the right marketing track... Last year there was 1.3 million in Revenues for the first two Qtrs... This Merck deal gives them 1.5 million in the second Qtr plus whatever they did in the first Qtr... It looks like the Revenue stream is starting to accelerate... I expect Bioject will now be in the news more frequently as it continues moving in the direction of becoming the vaccine delivery system of choice... Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next